Cytosurge AG

Cytosurge AG Leverage Cytosurge’s proprietary FluidFM® technology for precise, gentle single-cell manipulation and CRISPR engineering.

Our vision is to turn genetic designs into cures, bridging design and manufacturing > https://linktr.ee/cytosurge Cytosurge develops innovative research solutions using its proprietary FluidFM® technology for precise single-cell manipulation thereby fostering advancements in understanding cellular processes such as the ones that drive cancer. With the FluidFM OMNIUM platform, single-cell extracts, or “biopsies” can be taken from living cells, enabling live-sequencing and temporal transcriptomics analysis. Additionally, the CellEDIT Service provides high-quality genetically engineered cell lines through intra-nuclear injections of CRISPR RNPs. Cytosurge's vision is to unlock novel cures by translating next-generation genetic designs into living cells, enabling longer and healthier lives through precision gene engineering. The Company aims to implement advanced genetically engineered cell lines that bring next-generation therapies to fruition, bridging the gap between genetic design tools and manufacturing, and empowering genetic engineers to realize their visionary concepts.

28/11/2025

is here! CellEDIT 3for2 🖤🖤💜: order 2 custom CRISPR cell lines, get 1 FREE. Vector-free intranuclear delivery • Works on hard-to-transfect cells • Reduced off-targets • 10-week turnaround.

Redeem by connecting with Dr. Gorka Santos by Cyber Monday, 11:59 PM PT (midnight in California).

🛒💸💰

With 140+ installations worldwide 🌍, is powering research in many of the world’s leading labs 🔬✨. To deliver top-tier ...
26/11/2025

With 140+ installations worldwide 🌍, is powering research in many of the world’s leading labs 🔬✨. To deliver top-tier service wherever you work, we partner with trusted experts across Europe, Asia, and the Americas 🌎🤝.

Ready to turn your scientific vision into reality? 🚀💡 Contact us and we’ll connect you with the right local partner to support your journey 📩

24/11/2025

Black Friday Week for CellEDIT 🖤 Order 2 custom CRISPR cell lines, get 1 FREE (3 for 2).🖤 🖤 🖤
• Vector-free direct intranuclear delivery (FluidFM)
• Works on hard-to-transfect cells
• Reduced off-targets, precise QC
• Use cases: Point mutations, small KIs, tagging, multiplex KOs

To redeem, connect with our Sales Manager, Dr. Gorka Santos, by Cyber Monday, 11:59 PM PST 👇

🛒💸💰

20/11/2025

From our Cytosurge × Lexogen webinar, Dr. Ludovica Rizzo explains why snapshots aren’t enough. Instead of inferring fate from separate cell populations, Live-seq follows the same living cell over time, building a linked, longitudinal dataset that supports causal conclusions and actionable decisions. See how this shifts single-cell work from snapshots to time-resolved insights.

Watch the webinar recording | Check out the slides 👉 QR code at the end of the video | Link in the first comment

#6: iPSCs are powerful but fragile. Bulk delivery stresses them; outcomes vary. delivers CRISPR RNPs directly into ...
19/11/2025

#6: iPSCs are powerful but fragile. Bulk delivery stresses them; outcomes vary. delivers CRISPR RNPs directly into the nucleus for precise KOs/KIs while preserving pluripotency and clean colony recovery. Book a consultation with Dr. Santos 👇

18/11/2025

With OMNIUM, hands-free, high-throughput single-cell force spectroscopy ( ) becomes routine: minimal prep, no cell gluing, robust adhesion force curves, fast.

Check out the video for a myotubes demo showing real-time adhesion measurements, a semi-automated workflow (up to 25 cells/hour), and an extended force range up to 3 µN.
Unlock new insights into cell mechanics, adhesion dynamics, and mechanobiology.

Connect with us to turn your mechanobiology questions into measurable insights! LINK in the first comment.

Grateful to GenomeWeb and Huanjia Zhang for the coverage and for speaking with our CPO, Dario Ossola. The interview foll...
14/11/2025

Grateful to GenomeWeb and Huanjia Zhang for the coverage and for speaking with our CPO, Dario Ossola. The interview follows our announcement that the Live‑seq workflow, built on FluidFM and developed with Lexogen, is ready for academic and industrial researchers worldwide. 🚀

Interested in hearing directly from the scientists behind it? Watch the recording of our recent webinar with Lexogen. 🎥🧬 LINK IN THE FIRST COMMENT 👇

What Live‑seq enables:
> Minimally invasive cytoplasmic sampling via FluidFM
> Point‑and‑click operation on the FluidFM OMNIUM platform
> Ultra‑low input library prep optimized with Lexogen’s LUTHOR HD
> Practical throughput: ~1 extraction every 6–10 minutes (≈20 biopsies per half day)
> Ideal for tracking drug response, cell fate, and disease progression over time

Read the article > Cytosurge Eyes Slice of Single‑Cell Market With Live‑seq Technology > https://bit.ly/4p5XLdp

From novel technologies to clinical applications: driving the next generation of multi-omics research. 🚀🧬Join Cytosurge ...
13/11/2025

From novel technologies to clinical applications: driving the next generation of multi-omics research. 🚀🧬

Join Cytosurge at NextGen Omics, Spatial & Data UK 13 - 14 Nov. | London
📌 BOOTH #47
🗣️ Featured Talk, TODAY, 4:10 PM, conference room 3
“Cellular Time Travel: Determine Today’s Transcriptome, Study Tomorrow’s Response” presented by Marlies Mürnseer, International Sales & BD Manager. On-site, also our CCO, Dr. Magid Haddouchi.

What you’ll learn in the talk:
> How to sequence RNA from living cells while keeping them alive
> Tracking the same cell’s molecular changes across time points
> Capturing causally linked transcriptomic and phenotypic data
> Understanding cellular responses and fate decisions in real time
> Bridging spatial and temporal omics for deeper biological insight

United in purpose: where omics meets data analysis. Together, we can accelerate life‑saving treatments with innovation, cross‑border collaboration, and precision technology.

12/11/2025

Margot Le Bot, PhD student in the Physics of Cells and Cancer Unit at Institut Curie (supervised by Benoît Sorre and Leïla Perié), shares how and technology are transforming her research on epithelial-to-mesenchymal transition (EMT) in triple-negative breast cancer.

Using FluidFM biopsies and full-life experiments, Margot:
• Tracks the same living cancer cell over time to understand heterogeneity
• Maps transcriptomic changes during this dynamic transition process
Studies how initial cell states influence metastatic outcomes
• Plans to expand to chemotherapy responses and transitions

This work is conducted at Institut Curie in collaboration with the Single Cell Initiative, under the management of Dr. Leanne de Koning.

Link to the recording & slides of our recent Live-seq in the first comment.

Dr. Tobias Beyer (CSO) will be at the CSHL Single Cell Analyses Meeting, Nov 12–15, 2025 (Cold Spring Harbor Laborator...
11/11/2025

Dr. Tobias Beyer (CSO) will be at the CSHL Single Cell Analyses Meeting, Nov 12–15, 2025 (Cold Spring Harbor Laboratory, NY), presenting a 2‑minute flash talk and a poster: “The FluidFM Technology for Temporally Resolved Single Cell Analysis, Genome Engineering and Beyond.”

Meet him there and don’t miss this opportunity to discover how FluidFM’s versatile platform is pushing the boundaries of what’s possible in single‑cell biology.

World Science Day for Peace and Development 🌍🔬 Celebrated every 10 November, today spotlights science’s role in society—...
10/11/2025

World Science Day for Peace and Development 🌍🔬 Celebrated every 10 November, today spotlights science’s role in society—building public trust, accelerating transformation, and shaping a better tomorrow. This year’s theme: Trust, Transformation, and Tomorrow — The Science We Need for 2050.

UNESCO is marking the day at the 43rd session of the UNESCO General Conference in Samarkand, Uzbekistan. Everyone can watch the live side event and join the conversation. Watch live: https://bit.ly/3JTl7nC

Celebrating Marie Curie’s birthday — November 7, 1867 ✨ Pioneer of radioactivity, first woman to win a Nobel Prize, firs...
07/11/2025

Celebrating Marie Curie’s birthday — November 7, 1867 ✨ Pioneer of radioactivity, first woman to win a Nobel Prize, first person (and only woman) to win two Nobels in two different sciences, and the first woman to lecture at the Sorbonne. Her legacy is a blueprint for inclusive science and bold innovation. “Nothing in life is to be feared, it is only to be understood.” — Marie Curie

Adresse

Sägereistrasse 25
Glattbrugg
8152

Öffnungszeiten

Montag 09:00 - 18:00
Dienstag 09:00 - 18:00
Mittwoch 09:00 - 18:00
Donnerstag 09:00 - 18:00
Freitag 09:00 - 18:00

Telefon

+41445331450

Webseite

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Cytosurge AG erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Verknüpfungen

Teilen

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Our Story

Founded in 2009, Cytosurge AG successfully develops, manufactures and distributes cutting-edge and unique high-precision nanotechnology instruments as well as robotic systems based on its patented FluidFM® technology.

Whether via the FluidFM ADD-ON, a powerful upgrade solution for your AFM, the FluidFM BOT, a fully integrated system for cell research, or via the award-winning FluidFM µ3Dprinter for 3D metal printing at the micrometre scale, Cytosurge provides leading-edge tools and processes to those who need or want to go beyond current technological boundaries.

FluidFM – GO BEYOND.